Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in low-weight patients with atrial fibrillation. [PDF]
J Thromb ThrombolysisChen KH +6 more
europepmc +1 more source
Safety and efficacy of non-vitamin K antagonist oral anticoagulants compared with well-controlled warfarin in Thai patients with atrial fibrillation. [PDF]
Asian Biomed (Res Rev News), 2022 Yamkasikorn J, Methavigul K.
europepmc +1 more source
Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal [PDF]
, 2016 core +1 more source
Adherence and clinical outcomes for twice-daily versus once-daily dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: Is dosing frequency important? [PDF]
PLoS One, 2023 Hwang HJ, Sohn IS, Jin ES, Bae YJ.
europepmc +1 more source
Impact of insurance coverage for non-vitamin K antagonist oral anticoagulants on quality of care and care disparities in patients hospitalised with atrial fibrillation in tertiary hospitals in China: interrupted time series analysis. [PDF]
BMJ OpenYang N +7 more
europepmc +1 more source
Erratum to: Worldwide trends in antithrombotic therapy prescribing for atrial fibrillation: observations on the 'transition era' to non-vitamin K antagonist oral anticoagulants. [PDF]
Europace, 2023 europepmc +1 more source
Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis. [PDF]
Cochrane Database Syst RevAl Said S +8 more
europepmc +1 more source
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Compared with Vitamin K Antagonists in Patients with Atrial Fibrillation and Type 2 Valvular Heart Disease: A Systematic Review and Meta-Analysis. [PDF]
Cardiovasc Drugs TherLiang X +6 more
europepmc +1 more source